1369 related articles for article (PubMed ID: 32230811)
21. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
22. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
[TBL] [Abstract][Full Text] [Related]
23. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
24. Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.
Wainberg M; Andrews SJ; Tripathy SJ
Alzheimers Res Ther; 2023 Jun; 15(1):113. PubMed ID: 37328865
[TBL] [Abstract][Full Text] [Related]
25. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
27. Aggregation of Disordered Proteins Associated with Neurodegeneration.
Tsoi PS; Quan MD; Ferreon JC; Ferreon ACM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834792
[TBL] [Abstract][Full Text] [Related]
28. Effects of natural antioxidants in neurodegenerative disease.
Albarracin SL; Stab B; Casas Z; Sutachan JJ; Samudio I; Gonzalez J; Gonzalo L; Capani F; Morales L; Barreto GE
Nutr Neurosci; 2012 Jan; 15(1):1-9. PubMed ID: 22305647
[TBL] [Abstract][Full Text] [Related]
29. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
Tabassum R; Jeong NY
Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
32. The dawn of pirna research in various neuronal disorders.
Wakisaka KT; Imai Y
Front Biosci (Landmark Ed); 2019 Jun; 24(8):1440-1451. PubMed ID: 31136989
[TBL] [Abstract][Full Text] [Related]
33. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
34. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
35. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
[TBL] [Abstract][Full Text] [Related]
36. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
[TBL] [Abstract][Full Text] [Related]
37. Mitophagy Regulates Neurodegenerative Diseases.
Cen X; Zhang M; Zhou M; Ye L; Xia H
Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
[TBL] [Abstract][Full Text] [Related]
38. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
40. Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases.
Esposito S; Masala A; Sanna S; Rassu M; Pimxayvong V; Iaccarino C; Crosio C
Rev Neurosci; 2017 Feb; 28(2):133-144. PubMed ID: 28030361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
